Nature’s Sunshine Products ( (NATR) ) has released its Q1 earnings. Here is a breakdown of the information Nature’s Sunshine Products presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Nature’s Sunshine Products, Inc., a prominent player in the natural health and wellness sector, specializes in manufacturing and distributing high-quality herbal and nutritional supplements across more than 40 countries. In its latest earnings report for the first quarter of 2025, the company showcased a robust financial performance with net sales climbing 2% to $113.2 million, marking a 5% increase in constant currency terms. The company also reported a significant 104% rise in GAAP net income attributable to common shareholders, reaching $4.7 million, or $0.25 per diluted share.
Key highlights from the earnings report include a 20% increase in adjusted EBITDA to $11.0 million, driven by improved sales figures and effective cost management strategies. The company also announced a strategic move to repurchase up to $25 million of its common shares, indicating confidence in its financial health and commitment to enhancing shareholder value. Notably, the company experienced strong double-digit growth in Asian and European markets, while North America showed signs of stabilization.
The financial results were further bolstered by an increase in gross profit margin to 72.1%, up from 71.2% in the previous year, attributed to price adjustments and cost-saving initiatives. Operating income also saw an improvement, rising to $6.2 million compared to $4.6 million in the same quarter last year. The company maintained a strong balance sheet with cash and cash equivalents amounting to $86.5 million and no debt.
Looking ahead, Nature’s Sunshine remains optimistic about its growth prospects, projecting full-year 2025 net sales to range between $445 million and $470 million, with adjusted EBITDA expected to be between $38 million and $44 million. The company continues to focus on executing its global growth strategies and making disciplined investments to maximize returns for its shareholders.